Actually, you should have asked ME 12-3-03 - I would have told you I expect not much from ABRX in 2004. I was very clear on that as they were moving to bigger facilities and, as much, would report lots of one-time costs and indirect costs with disruptions, inactive lines while awaiting FDA approval, etc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.